Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis

Ophthalmology

Volumn 119, Issue 1, 2012, Pages 66-73

  Cohen, Amy E ^a   Assang, Carol ^a   Patane, Michael A ^a   From, Stephen ^a   Korenfeld, Michael ^b  

^a Jade Therapeutics Inc   (United States)

^b Comprehensive Eye Care Ltd ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; EGP 437; PREDNISOLONE ACETATE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; IONTOPHORESIS; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; NONINFECTIOUS ANTERIOR UVEITIS; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; TREATMENT DURATION; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; UVEITIS; VISUAL ACUITY;

ADULT; AGED; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IONTOPHORESIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEITIS, ANTERIOR; YOUNG ADULT;

EID: 84855320097     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.07.006     Document Type: Article

References (22)

1. Bora NS, Kaplan HJ. Intraocular diseases-anterior uveitis. Chem Immunol Allergy 2007;92:213-20.
2. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004;111:491-500. (Pubitemid 38293104)
3. Reeves SW, Sloan FA, Lee PP, Jaffe GJ. Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology 2006;113:302-7.
4. Abelson M, Foster CS, Gupta G. Diagnosing and managing anterior uveitis. Rev Ophthalmol 2002;9:110-4.
5. Samudre SS, Lattanzio FA Jr, Williams PB, Sheppard JD Jr. Comparison of topical steroids for acute anterior uveitis. J Ocul Pharmacol Ther 2004;20:533-47. (Pubitemid 39628498)
6. Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006;27:413-26. (Pubitemid 43185854)
7. Nguyen QD, Hatef E, Kayen B, et al. A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology 2011;118:184-90.
8. Foster CS, Vitale AT. Diagnosis and Treatment of Uveitis. Philadelphia: Saunders; 2002:141-57.
9. Sherif Z, Pleyer U. Corticosteroids in ophthalmology: past-present-future. Ophthalmologica 2002;216:305-15.
10. Raviola G. The structural basis of the blood-ocular barriers. Exp Eye Res 1977;25(suppl):27-63. (Pubitemid 8205026)
11. Eljarrat-Binstock E, Pe'er J, Domb AJ. New techniques for drug delivery to the posterior eye segment. Pharm Res 2010;27:530-43.
12. von Sallmann L. Iontophoretic introduction of atropine and scopolamine into the rabbit eye. Arch Ophthalmol 1943;29:711-9.
13. Hughes L, Maurice DM. A fresh look at iontophoresis. Arch Ophthalmol 1984;102:1825-9. (Pubitemid 15184178)
14. Jones RF, Maurice DM. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res 1966;5:208-20.
15. Lam TT, Edward DP, Zhu XA, Tso MO. Transscleral iontophoresis of dexamethasone. Arch Ophthalmol 1989;107:1368-71. (Pubitemid 19229084)
16. Yoo SH, Dursun D, Dubovy S, et al. Iontophoresis for the treatment of Paecilomyces keratitis. Cornea 2002;21:131-2. (Pubitemid 33144421)
17. Parkinson T, Ferguson E, Febbraro S, et al. Tolerance of ocular iontophoresis in healthy volunteers. J Ocul Pharmacol Ther 2003;19:145-51. (Pubitemid 36539140)
18. Behar-Cohen FF, El Aouni A, Gautier S, et al. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp Eye Res 2002;74:51-9. (Pubitemid 34948265)
19. Horwath-Winter J, Schmut O, Haller-Schober EM, et al. Iodide iontophoresis as a treatment for dry eye syndrome. Br J Ophthalmol 2005;89:40-4. (Pubitemid 40040236)
20. Güngör S, Delgado-Charro MB, Ruiz-Perez B, et al. Transscleral iontophoretic delivery of low molecular weight therapeutics. J Control Release 2010;147:225-31.
21. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004;137:337-42. (Pubitemid 38221009)
22. Ruiz-Perez B, Dowie T, Gee R, et al. Transscleral delivery of a 12.4 kDa protein by ocular iontophoresis. Invest Ophthalmol Vis Sci 2008;49:1813.